Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Shao Binhao"'
Autor:
Xu, Wei a, †, Huang, Junjun b, †, Shao, Binhao b, Xu, Xingjie b, Jiang, Renwang a, ⁎, Yuan, Mu b, ⁎
Publikováno v:
In Bioorganic & Medicinal Chemistry 1 November 2016 24(21):5565-5572
Publikováno v:
In Journal of Molecular Structure 15 February 2016 1106:485-490
Autor:
Xu, Fang a, ⁎, †, Chen, Hong b, †, Xu, Jingyi c, Liang, Xue c, He, Xuelan c, Shao, Binhao c, Sun, Xianqiang d, Li, Bing e, Deng, Xiaoliang e, Yuan, Mu c, ⁎
Publikováno v:
In Bioorganic & Medicinal Chemistry 15 December 2015 23(24):7735-7742
Publikováno v:
Chinese Chemical Letters. 27:277-282
A series of novel arylpiperazine derivatives was synthesized. The in vitro cytotoxic activities of all synthesized compounds against three human prostate cancer cell lines (PC-3, LNCaP, and DU145) were evaluated by a CCK-8 assay. Compounds 8, 10, 13,
Autor:
Yuan Mu, He Xuelan, Shao Binhao, Jingyi Xu, Fang Xu, Bing Li, Hong Chen, Xue Liang, Xiaoliang Deng, Xianqiang Sun
Publikováno v:
Bioorganic & Medicinal Chemistry. 23:7735-7742
A series of novel arylpiperazine derivatives as α1A/1D-adrenergic receptors (AR) subtype selective antagonists were designed, synthesized and evaluated for their antagonistic activities towards α1-ARs (α1A, α1B, and α1D). Compounds 9, 12, 13, 15
Publikováno v:
Bioorganicmedicinal chemistry. 24(21)
Subtype-selective α1-adrenoceptor (AR) antagonists display optimum therapeutic efficacies for the treatment of benign prostatic hyperplasia (BPH). In this study, we designed and synthesized novel carbazole-arylpiperazines derivatives (1 and 2) on th